NIRSense Supports US Army with Tissue Oxygenation Assessment at Balikatan-26
NIRSense, Inc. has announced its support for the US Army Pacific during the Balikatan-26 exercise by providing portable tissue oxygen saturation monitoring technology. This technology aims to enhance battlefield casualty assessment and improve decision-making in combat situations by offering real-time insights into tissue perfusion and oxygen delivery. NIRSense’s non-invasive system can assist operational medical teams in triaging and managing injured personnel more effectively, going beyond traditional vital signs.
RICHMOND, Va., May 9, 2026 /PRNewswire/ — NIRSense, Inc. today announced its participation in Balikatan-26, supporting the US Army Pacific (USARPAC)’s 18th Theater Medical Command (18th TMC) as they evaluate advanced approaches to battlefield casualty assessment using portable tissue…